| June 1 |
AstraZeneca and Merck & Co., Inc. Form Pioneering Collaboration to Investigate Novel Combination Anticancer Regimen |
| June 2 |
Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in Advanced Breast Cancer |
| June 2 |
Genzyme Completes Transaction with Bayer HealthCare |
| June 2 |
TorreyPines Therapeutics Announces its Board of Directors' Approval of Plan of Liquidation and Dissolution |
| June 2 |
FDA Warnings About Antidepressants Associated With Lasting, Unintended Changes in Diagnosis and Treatment |
| June 2 |
Drug Industry Marketing Direct to Consumers and Doctors May Lead to Prescription Overuse |
| June 2 |
PharmaLive.com Launches New Report on DTC Ad Spending |
| June 2 |
Concert Pharmaceuticals and GlaxoSmithKline Form Alliance to Develop Novel Deuterium Modified Drugs |
| June 2 |
Bio-Imaging Technologies and etrials Worldwide Merger Agreement Terminated |
| June 3 |
Advaxis Receives FDA Response to Orphan Drug Filing |
| June 3 |
FDA Forms Transparency Task Force |
| June 3 |
Almotriptan (Axert/Almogran) Approved by the FDA for the Treatment of Migraine in Adolescents |
| June 3 |
Pfizer Announces Completion Of European Debt Offering |
| June 3 |
FDA MedWatch - Propylthiouracil (PTU) associated with risk of serious liver injury, including liver failure and death |
| June 3 |
Genmab Announces Partial Clinical Hold on Zalutumumab Studies |
| June 4 |
Adolor Corporation Announces Staff Reductions and Restructuring |
| June 4 |
FDA Warns About Serious Liver Injury Associated With Anti-Thyroid Drug |
| June 4 |
Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of Trilipix (fenofibric acid) |
| June 4 |
Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598 |
| June 4 |
Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs |
| June 5 |
Potential Signals of Serious Risks/New Safety Information Identified from the Adverse Event Reporting System (AERS) between October - December 2008 |
| June 8 |
Aileron Therapeutics Closes $40 Million Series D Financing |
| June 8 |
Jean-Philippe Santoni Appointed Senior Vice President, Industrial Development and Innovation |
| June 8 |
EU-wide Recall of Raptiva (efalizumab) to be Initiated |
| June 8 |
Sanofi-aventis to Purchase Diabel Manufacturing Facility in Frankfurt to Strengthen Insulin Production Capacities |
| June 8 |
Alder Biopharmaceuticals Announces Expanded Collaboration With Schering-Plough |
| June 8 |
Commonwealth Biotechnologies, Inc. Announces Agreement to Acquire GL Biochem (Shanghai) Ltd |
| June 9 |
CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement |
| June 9 |
House Committee on Energy and Commerce Chairman Waxman Writes President Obama Regarding Generic Biologics |
| June 9 |
Progenics Provides Update on Hepatitis C Program |
| June 9 |
Merck & Co.: Corporations Need to Tackle Global Corruption as Strategic CSR Effort |
| June 9 |
GSK and Shenzhen Neptunus Create New Alliance to Develop and Manufacture Influenza Vaccines in China |
| June 9 |
NAACP & Nine Class Reps File Motion for Class Certification Against Eli Lilly in Pervasive Discrimination Case |
| June 10 |
Robert A. McDonald Elected President and Chief Executive of P&G |
| June 11 |
Xenon Enters Cardiovascular Disease Collaboration With Merck & Co., Inc. |
| June 11 |
FTC Releases Report on ?Follow-on Biologic Drug Competition? |
| June 11 |
Neuromed Announces that Merck & Co., Inc. Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels |
| June 11 |
TNS Media Intelligence Reports U.S. Advertising Expenditures Declined 14.2 Percent First Quarter 2009 |
| June 11 |
Commonwealth Biotechnologies, Inc. Provides Market Update on Contemplated Acquisition of GL Biochem |
| June 12 |
Cumberland Pharmaceuticals Announces FDA Approval of Caldolor |
| June 12 |
ImmunoGen, Inc. Elects to Discontinue Further Internal Development of Its IMGN242 Compound |
| June 12 |
Oscient Pharmaceuticals Discontinues Sales Force Promotion for Antara and Factive |
| June 12 |
Genaera Corporation Board of Directors Dissolves Corporation and Forms Liquidating Trust |
| June 12 |
61% of American Adults Look Online for Health Information |
| June 15 |
Boehringer Ingelheim and Vitae Pharmaceuticals Announce a Major Collaboration to Research and Develop Novel Treatments for Alzheimer`s disease |
| June 15 |
Synta and GSK End Elesclomol Collaboration Agreement |
| June 15 |
Dr. Reddy's Announces Strategic Alliance with GSK for Emerging Markets |
| June 16 |
FDA Issues Safety Communication about an Ongoing Review of Stimulant Medications Used in Children with ADHD |
| June 16 |
FDA Warns Web Sites Against Marketing Fraudulent H1N1 Flu Virus Claims |
| June 16 |
Eli Lilly and Company Announces New Drug Discovery Initiative |
| June 16 |
Genzyme Temporarily Interrupts Production at Allston Plant |
| June 16 |
Adimab Launches Novel Antibody Discovery Platform and Announces Discovery Programs with Merck and Roche |
| June 17 |
Watson to Acquire Arrow Group |
| June 17 |
Biogen Idec Announces Conclusion of Arbitration with Genentech |
| June 17 |
Health Care Reform May Force U.S. Pharmaceutical Companies to Overhaul Sales Strategies, Says New Report From ZS Associates and eyeforpharma |
| June 18 |
Manhattan Pharmaceuticals Provides Corporate Update on Hedrin and Management Restructuring |
| June 18 |
Cefepime (marketed as Maxipime) Update of Ongoing Safety Review |
| June 18 |
S&P: Europe's Pharmaceutical Firms Buck The Recession With Strong Sales Growth In 2009, Says Report |
| June 19 |
FDA Grants The Medicines Company Pediatric Exclusivity for Angiomax |
| June 19 |
Hospira Receives Favorable Court Decision on Eloxatin |
| June 19 |
Pharmaceutical Company Manager Sentenced For Off-Label Marketing |
| June 22 |
Merck & Co., Inc. Statement on Medicare Part D Assistance |
| June 22 |
Vical Receives Milestone Payment From Merck & Co., Inc. |
| June 22 |
NeurogesX and Astellas Enter Commercialization Agreement for Qutenza |
| June 22 |
Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger |
| June 22 |
PhRMA Statement on the Health Care Reform Agreement |
| June 22 |
Biogen Idec Announces First Patient Enrolled in the Global Phase III Study of PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis |
| June 22 |
KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10-K |
| June 23 |
Merck Prices $4.25 Billion Debt Offering |
| June 23 |
Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration |
| June 23 |
Cell Genesys Announces Tender Offer Results While Continuing to Pursue Strategic Alternatives |
| June 23 |
Deductibility of Prescription Drug Ads May Be Under Threat |
| June 23 |
GSK and Chroma Therapeutics Form Alliance to Develop Novel Macrophage-Targeted Drugs |
| June 23 |
Mass. AG Martha Coakley?s Office Files Complaint Against Drug Manufacturer Wyeth |
| June 23 |
PharmaLive.com Launches New Pipeline Report |
| June 24 |
Medifacts Acquires Spacelabs Healthcare Clinical Trials Services Division |
| June 24 |
Takeda Announces Completion of Tender Offer for All Outstanding Shares of IDM Pharma, Inc. |
| June 24 |
Faes Farma and Pfizer Are Negotiating Semi Exclusive Licences for Bilastine in Certain Countries |
| June 24 |
Teva Pharmaceuticals Issues Statement in Response to Federal Trade Commission Claims on Patent Settlements |
| June 25 |
Baxter to Acquire Continuous Renal Replacement Therapy Business from Edwards Lifesciences |
| June 25 |
Novo Growth Equity Expands Team, and Will Invest Up to $200M Per Year |
| June 25 |
Sen. Grassley Seeks Information About Medical School Policies for Disclosure of Financial Ties |
| June 25 |
Uluru Discussions to Acquire York Pharma, plc Are Currently Terminated |
| June 25 |
ONGLYZA (Saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes |
| June 26 |
U.S. Marshals Seize Drug Products Manufactured by Caraco Pharmaceutical Laboratories Ltd. |
| June 26 |
Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial Position |
| June 26 |
CHMP Issue Opinions |
| June 26 |
Announcement of Establishment of a Holding Company in the U.S. |
| June 26 |
Novo Nordisk Reaches Settlement With the Danish Authorities Regarding Oil-for-Food Activities |
| June 26 |
Boston Scientific Announces Retirement of Jim Tobin and Appointment of Ray Elliott as New President and CEO |
| June 28 |
Sanofi-aventis Stands Behind the Safety of Lantus |
| June 28 |
Jerini AG (DE) - Ad hoc: Jerini AG to Wind Down its Preclinical Programs |
| June 29 |
A Side Effect of Michael Jackson’s Tragic Death – Consumer Health Education |
| June 29 |
Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets |
| June 29 |
Simponi (Golimumab) Receives Positive Opinion from Chmp for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis |
| June 29 |
ChemGenex to Seek Voluntary De-Listing From NASDAQ and to Restructure Board to Reflect Compliance Needs |
| June 29 |
Christian Lajoux Appointed President for sanofi-aventis in France |
| June 29 |
UCB Brings Neupro Back to All Patients in Europe |
| June 29 |
FDA Sends Romark Laboratories Warning Letter About Statements on Alinia Sales |
| June 29 |
FDA Reviews Mailer from Millennium Pharmaceuticals for Velcade |
| June 30 |
Sanofi-Aventis Presents New R&D Model Project to Boost Innovation |
| June 30 |
Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories |
| June 30 |
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement |
| June 30 |
UCB (BE) - UCB and Biogen Idec Discontinue Phase II Clinical Trial of CDP323 |
| June 30 |
Collegium Pharmaceutical Announces the Sale of AllerNaze to Lupin |
| June 30 |
Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer |
